Per Pfeiffer

Odense University Hospital

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

Elke Van Daele

Ghent University Hospital

BELGIUM

View details

Jan-Erik Frodin

Karolinska Institutet

SWEDEN

View details

Lise Ventzel

MD PhD Associate Professor

Herlev Hospital

DENMARK

View details

Stefan Kasper

Professor of Medical Oncology

GERMANY

View details

Benny V. Jensen

DENMARK

View details

Tobias Freyberg Justesen

Zealand University Hospital

DENMARK

View details

Hanneke W. M. van Laarhoven

NETHERLANDS

View details

Maarit Bärlund

University of Tampere

FINLAND

View details

Morten Ladekarl

Aalborg University

DENMARK

View details

Christian Rønn Hansen

Odense University Hospital

DENMARK

View details

Hanna Rahbek Mortensen

Associate Professor

Aarhus University

DENMARK

View details

Alessio Giuseppe Morganti

ALMA MATER STUDIORUM UNIVERSITY OF BOLOGNA

ITALY

View details

Camiel Rosman

Radboud University Medical Center

NETHERLANDS

View details

Stephen Hamilton-Dutoit

Aarhus University

DENMARK

View details

Ioannis Rouvelas

Karolinska Institutet

SWEDEN

View details

Gabor Liposits

Aarhus University

DENMARK

View details

Lasse Sommer Kristensen

Aarhus University

DENMARK

View details

Anna Dorothea Wagner

Senior lecturer, consultant and head of the gastrointestinal cancer outpatient clinic

Lausanne University Hospital

SWITZERLAND

View details

Jesper Ryg

Professor

Odense University Hospital

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Per Pfeiffer

Research Interests

Contact this professor

Articles (21)

Effect of comprehensive geriatric assessment on hospitalizations in older adults with frailty initiating curatively intended oncologic treatment

Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)

Cetuximab Every 2 Weeks Versus Standard Weekly Dosing Administration Schedule

Adaptive MRI-guided stereotactic body radiation therapy for locally advanced pancreatic cancer – A phase II study

Exploring the prognostic value of circular RNAs in pancreatic ductal adenocarcinoma using genome-wide expression profiling

European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)

RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)

TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1)

The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study

Feasibility and Safety of Laparoscopic D2 Gastrectomy in Combination with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Gastric Cancer at High Risk of Recurrence-The PIPAC-OPC4 Study.

Prognostic significance of margin clearance in pancreaticoduodenectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study

A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe.

Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies

Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer

Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials

Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer

Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy

Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer

Collaborators (19)

Elke Van Daele

Jan-Erik Frodin

Lise Ventzel

Stefan Kasper

Benny V. Jensen

Tobias Freyberg Justesen

Hanneke W. M. van Laarhoven

Maarit Bärlund

Morten Ladekarl

Christian Rønn Hansen

Hanna Rahbek Mortensen

Alessio Giuseppe Morganti

Camiel Rosman

Stephen Hamilton-Dutoit

Ioannis Rouvelas

Gabor Liposits

Lasse Sommer Kristensen

Anna Dorothea Wagner

Jesper Ryg

Make your next move.